Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 422-427

  Kanaoka, Shigeru ^a   Yoshida, Ken Ichi ^a   Miura, Naoyuki ^a   Sugimura, Haruhiko ^a   Kajimura, Masayoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

carcinoembryonic antigen; CEA; CI; colorectal cancer; confidence interval; COX 2; CRC; cyclooxygenase 2; reverse transcription polymerase chain reaction; RT PCR

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FECES ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SAMPLING;

EID: 4143075835     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.05.022     Document Type: Article

References (34)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15-36
2. Garfinkel L., Mushinski M. U.S. cancer incidence, mortality and survival 1973-1996. Stat Bull Metrop Insur Co. 80:1999;23-32
3. The Editorial Board of Cancer Statistics in Japan. Cancer Statistics in Japan-2001. 2001;Foundation for Promotion of Cancer Research, Tokyo
4. Eisenberg B., Decosse J.J., Harford F., Michalek J. Carcinoma of the colon and rectum the natural history reviewed in 1704 patients. Cancer. 49:1982;1131-1134
5. Frazier A.L., Colditz G.A., Fuchs C.S., Kuntz K.M. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 284:2000;1954-1961
6. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 328:1993;1365-1371
7. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 348:1996;1467-1471
8. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., James P.D., Mangham C.M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 348:1996;1472-1477
9. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res. 87:1996;1011-1024
10. Sidransky D., Tokino T., Hamilton S.R., Kinzler K.W., Levin B., Frost P., Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 256:1992;102-105
11. Eguchi S., Kohara N., Komuta K., Kanematsu T. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer. 77:1996;1707-1710
12. Ahlquist D.A., Skoletsky J.E., Boynton K.A., Harrington J.J., Mahoney D.W., Pierceall W.E., Thibodeau S.N., Shuber A.P. Colorectal cancer screening by detection of altered human DNA in stool feasibility of a multitarget assay panel. Gastroenterology. 119:2000;1219-1227
13. Dong S.M., Traverso G., Johnson C., Geng L., Favis R., Boynton K., Hibi K., Goodman S.N., D'Allessio M., Paty P., Hamilton S.R., Sidransky D., Barany F., Levin B., Shuber A., Kinzler K.W., Vogelstein B., Jen J. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst. 93:2001;858-865
14. Traverso G., Shuber A., Levin B., Johnson C., Olsson L., Schoetz D.J. Jr, Hamilton S.R., Boynton K., Kinzler K.W., Vogelstein B. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 346:2002;311-320
15. Traverso G., Shuber A., Olsson L., Levin B., Johnson C., Hamilton S.R., Boynton K., Kinzler K.W., Vogelstein B. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet. 359:2002;403-404
16. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767
17. Boland C.R., Sato J., Saito K., Carethers J.M., Marra G., Laghi L., Chauhan D.P. Genetic instability and chromosomal aberrations in colorectal cancer a review of the current models. Cancer Detect Prev. 22:1998;377-382
18. Davidson L.A., Jiang Y.H., Lupton J.R., Chapkin R.S. Noninvasive detection of putative biomarkers for colon cancer using fecal messenger RNA. Cancer Epidemiol Biomarkers Prev. 4:1995;643-647
19. Davidson L.A., Aymond C.M., Jiang Y.H., Turner N.D., Lupton J.R., Chapkin R.S. Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA putative biomarkers for colon cancer. Carcinogenesis. 19:1998;253-257
20. Alexander R.J., Raicht R.F. Purification of total RNA from human stool samples. Dig Dis Sci. 43:1998;2652-2658
21. Yamao T., Matsumura Y., Shimada Y., Moriya Y., Sugihara K., Akasu T., Fujita S., Kakizoe T. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology. 114:1998;1196-1205
22. Mohan S., Epstein J.B. Carcinogenesis and cyclooxygenase the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol. 39:2003;537-546
23. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188
24. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789
25. Hao X., Bishop A.E., Wallace M., Wang H., Willcocks T.C., Maclouf J., Polak J.M., Knight S., Talbot I.C. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol. 187:1999;295-301
26. Gerhard M., Juhl H., Kalthoff H., Schreiber H.W., Wagener C., Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 12:1994;725-729
27. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 221:1994;889-897
28. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159
29. Ahlquist D.A., Harrington J.J., Burgart L.J., Roche P.C. Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa relevance to exfoliation and stool screening. Hum Pathol. 31:2000;51-57
30. Albaugh G.P., Iyengar V., Lohani A., Malayeri M., Bala S., Nair P.P. Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int J Cancer. 52:1992;347-350
31. Chung K., Mullick T., Motevalli S., Vinayek S., Tantry U., Nair P., Dutta S. Evaluation of sensitivity and specificity of CD44 expression in fecal colonocytes as a noninvasive marker for detecting colonic polyps and cancer. Gastroenterology. 114:1998;A580
32. Harrington J., Limburg P., Roche P., Klee G., Simko V., Ahlquist D. Interference of fecal colonocyte recovery by endogenous cytolysis. Gastroenterology. 114:1998;A607
33. Hammarstrom S. The carcinoembryonic antigen (CEA) family structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 9:1999;67-81
34. Jothy S., Yuan S.Y., Shirota K. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model. Am J Pathol. 143:1993;250-257